<DOC>
	<DOCNO>NCT00073034</DOCNO>
	<brief_summary>EAA-090 develop treatment neuropathic pain associate diabetic neuropathy . It selective antagonist bind competitively glutamate site N-methyl-D-aspartate ( NMDA ) receptor . This study ass safety efficacy 3 fixed oral dos EAA-090 compare placebo subject neuropathic pain associate diabetic neuropathy .</brief_summary>
	<brief_title>Study Evaluating EAA-090 Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Women childbearing potential must negative serum pregnancy test result screen Diabetes mellitus ( type I II ) control oral parenteral hypoglycemic agent diet Diagnosis painful diabetic distal symmetric sensory/motor polyneuropathy Pregnancy , lactation , plan become pregnant study DepoProvera oral contraceptive take less 1 month study day 1 use another medically accept form birth control History multiple drug allergy may put subject great risk study participation opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Neuropathic Pain</keyword>
	<keyword>Diabetic Neuropathy</keyword>
</DOC>